Skip to main content
Erschienen in: Endocrine 2/2024

12.10.2023 | Original Article

The mystery of transient pregnancy-induced cushing’s syndrome: a case report and literature review highlighting GNAS somatic mutations and LHCGR overexpression

verfasst von: Yufei Li, Jianfan Lin, Shien Fu, Li Li, Zhenxing Huang, Haiyan Yang, Xinghuan Liang, Yingfen Qin, Jia Zhou, Deyun Liu, Zuojie Luo

Erschienen in: Endocrine | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Transient pregnancy-induced Cushing’s syndrome is a rare condition characterized by the manifestation of symptoms solely during pregnancy, which typically resolve spontaneously following delivery or miscarriage. While it has been established that GNAS is associated with adrenal tumors, its specific role in the pathogenesis of pregnancy-induced Cushing’s syndrome remains uncertain.This work aims to examine the association between GNAS mutation and pregnancy-induced Cushing’s syndrome.

Methods

DNA was extracted from patients’ peripheral blood and tumor tissues for whole-exome sequencing (WES) and Sanger sequencing. We used AlphaFold to predict the protein structure of wild-type and mutant GNAS and to make functional predictions, and immunohistochemistry was used to detect disease-associated protein expression. A review and summary of reported cases of transient pregnancy-induced Cushing’s syndrome induced by pregnancy was conducted.

Results

Using WES, we identified a somatic mutation in GNAS (NM_000516, c.C601T, p.R201C) that was predicted to have a deleterious effect using computational methods, such as AlphaFold. Human chorionic gonadotropin (hCG) stimulation tests had weakly positive results, and immunohistochemical staining of adrenal adenoma tissue also revealed positivity for luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and cytochrome P450 family 11 subfamily B member 1 (CYP11B1). We reviewed 15 published cases of transient Cushing’s syndrome induced by pregnancy. Among these cases, immunohistochemical staining of the adrenal gland showed positive LHCGR expression in 3 case reports, similar to our findings.

Conclusion

Transient pregnancy-induced Cushing’s syndrome may be associated with somatic GNAS mutations and altered adrenal pathology due to abnormal activation of LHCGR.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386(9996), 913–927 (2015)CrossRefPubMed A. Lacroix, R.A. Feelders, C.A. Stratakis, L.K. Nieman, Cushing’s syndrome. Lancet 386(9996), 913–927 (2015)CrossRefPubMed
2.
Zurück zum Zitat N. Younes, M. St-Jean, I. Bourdeau, A. Lacroix, Endogenous Cushing’s syndrome during pregnancy. Rev. Endocr. Metab. Disord. 24(1), 23–38 (2023)CrossRefPubMed N. Younes, M. St-Jean, I. Bourdeau, A. Lacroix, Endogenous Cushing’s syndrome during pregnancy. Rev. Endocr. Metab. Disord. 24(1), 23–38 (2023)CrossRefPubMed
3.
Zurück zum Zitat J. Kero, M. Poutanen, F.P. Zhang et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J. Clin. Invest 105(5), 633–641 (2000)CrossRefPubMedPubMedCentral J. Kero, M. Poutanen, F.P. Zhang et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J. Clin. Invest 105(5), 633–641 (2000)CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat U. Plöckinger, M. Chrusciel, M. Doroszko et al. Functional implications of LH/hCG receptors in pregnancy-induced cushing syndrome. J. Endocr. Soc. 1(1), 57–71 (2017)PubMedPubMedCentral U. Plöckinger, M. Chrusciel, M. Doroszko et al. Functional implications of LH/hCG receptors in pregnancy-induced cushing syndrome. J. Endocr. Soc. 1(1), 57–71 (2017)PubMedPubMedCentral
7.
Zurück zum Zitat B. Yariv, E. Yariv, A. Kessel et al. Using evolutionary data to make sense of macromolecules with a “face-lifted” ConSurf. Protein Sci. 32(3), e4582 (2023)CrossRefPubMedPubMedCentral B. Yariv, E. Yariv, A. Kessel et al. Using evolutionary data to make sense of macromolecules with a “face-lifted” ConSurf. Protein Sci. 32(3), e4582 (2023)CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat X. Liu, C. Li, C. Mou, Y. Dong, Y. Tu, dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med 12(1), 103 (2020)CrossRefPubMedPubMedCentral X. Liu, C. Li, C. Mou, Y. Dong, Y. Tu, dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med 12(1), 103 (2020)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat D. Szklarczyk, R. Kirsch, M. Koutrouli et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1), D638–d646 (2023)CrossRefPubMed D. Szklarczyk, R. Kirsch, M. Koutrouli et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1), D638–d646 (2023)CrossRefPubMed
11.
Zurück zum Zitat F. Caimari, E. Valassi, P. Garbayo et al. Cushing’s syndrome and pregnancy outcomes: a systematic review of published cases. Endocrine 55(2), 555–563 (2017)CrossRefPubMed F. Caimari, E. Valassi, P. Garbayo et al. Cushing’s syndrome and pregnancy outcomes: a systematic review of published cases. Endocrine 55(2), 555–563 (2017)CrossRefPubMed
12.
Zurück zum Zitat S. Li, C. Yang, J. Fan et al. Pregnancy-induced Cushing’s syndrome with an adrenocortical adenoma overexpressing LH/hCG receptors: a case report. BMC Endocr. Disord. 20(1), 62 (2020)CrossRefPubMedPubMedCentral S. Li, C. Yang, J. Fan et al. Pregnancy-induced Cushing’s syndrome with an adrenocortical adenoma overexpressing LH/hCG receptors: a case report. BMC Endocr. Disord. 20(1), 62 (2020)CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat E. Reschini, G. Giustina, P.G. Crosignani, A. D’Alberton, Spontaneous remission of Cushing syndrome after termination of pregnancy. Obstet. Gynecol. 51(5), 598–602 (1978)CrossRefPubMed E. Reschini, G. Giustina, P.G. Crosignani, A. D’Alberton, Spontaneous remission of Cushing syndrome after termination of pregnancy. Obstet. Gynecol. 51(5), 598–602 (1978)CrossRefPubMed
14.
Zurück zum Zitat C.E. Andreescu, R.A. Alwani, J. Hofland et al. Adrenal Cushing’s syndrome during pregnancy. Eur. J. Endocrinol. 177(5), K13–k20 (2017)CrossRefPubMed C.E. Andreescu, R.A. Alwani, J. Hofland et al. Adrenal Cushing’s syndrome during pregnancy. Eur. J. Endocrinol. 177(5), K13–k20 (2017)CrossRefPubMed
15.
Zurück zum Zitat C. Ruggiero, E. Lalli, Impact of ACTH signaling on transcriptional regulation of steroidogenic genes. Front Endocrinol. (Lausanne) 7, 24 (2016)CrossRefPubMed C. Ruggiero, E. Lalli, Impact of ACTH signaling on transcriptional regulation of steroidogenic genes. Front Endocrinol. (Lausanne) 7, 24 (2016)CrossRefPubMed
16.
Zurück zum Zitat D. Goricanec, R. Stehle, P. Egloff et al. Conformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding. Proc. Natl. Acad. Sci. USA 113(26), E3629–E3638 (2016)CrossRefPubMedPubMedCentral D. Goricanec, R. Stehle, P. Egloff et al. Conformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding. Proc. Natl. Acad. Sci. USA 113(26), E3629–E3638 (2016)CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat M. Lodish, C.A. Stratakis, A genetic and molecular update on adrenocortical causes of Cushing syndrome. Nat. Rev. Endocrinol. 12(5), 255–262 (2016)CrossRefPubMed M. Lodish, C.A. Stratakis, A genetic and molecular update on adrenocortical causes of Cushing syndrome. Nat. Rev. Endocrinol. 12(5), 255–262 (2016)CrossRefPubMed
18.
Zurück zum Zitat L.S. Weinstein, A. Shenker, P.V. Gejman et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med 325(24), 1688–1695 (1991)CrossRefPubMed L.S. Weinstein, A. Shenker, P.V. Gejman et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med 325(24), 1688–1695 (1991)CrossRefPubMed
19.
20.
Zurück zum Zitat J. Rege, J. Hoxie, C.J. Liu et al. Targeted mutational analysis of cortisol-producing adenomas. J. Clin. Endocrinol. Metab. 107(2), e594–e603 (2022)CrossRefPubMed J. Rege, J. Hoxie, C.J. Liu et al. Targeted mutational analysis of cortisol-producing adenomas. J. Clin. Endocrinol. Metab. 107(2), e594–e603 (2022)CrossRefPubMed
21.
Zurück zum Zitat K. Takedani, M. Yamamoto, S. Tanaka et al. ACTH-independent Cushing’s syndrome due to ectopic endocrinologically functional adrenal tissue caused by a GNAS heterozygous mutation: a rare case of McCune-Albright syndrome accompanied by central amenorrhea and hypothyroidism: a case report and literature review. Front Endocrinol. (Lausanne) 13, 934748 (2022)CrossRefPubMed K. Takedani, M. Yamamoto, S. Tanaka et al. ACTH-independent Cushing’s syndrome due to ectopic endocrinologically functional adrenal tissue caused by a GNAS heterozygous mutation: a rare case of McCune-Albright syndrome accompanied by central amenorrhea and hypothyroidism: a case report and literature review. Front Endocrinol. (Lausanne) 13, 934748 (2022)CrossRefPubMed
22.
Zurück zum Zitat M.C. Fragoso, S. Domenice, A.C. Latronico et al. Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J. Clin. Endocrinol. Metab. 88(5), 2147–2151 (2003)CrossRefPubMed M.C. Fragoso, S. Domenice, A.C. Latronico et al. Cushing’s syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J. Clin. Endocrinol. Metab. 88(5), 2147–2151 (2003)CrossRefPubMed
23.
25.
Zurück zum Zitat J.E. Pabon, X. Li, Z.M. Lei et al. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 81(6), 2397–2400 (1996)PubMed J.E. Pabon, X. Li, Z.M. Lei et al. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 81(6), 2397–2400 (1996)PubMed
26.
Zurück zum Zitat O. Hatano, A. Takakusu, M. Nomura, K. Morohashi, Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1(7), 663–671 (1996)CrossRefPubMed O. Hatano, A. Takakusu, M. Nomura, K. Morohashi, Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1(7), 663–671 (1996)CrossRefPubMed
27.
Zurück zum Zitat A.E. Teo, S. Garg, L.H. Shaikh et al. Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations. N. Engl. J. Med. 373(15), 1429–1436 (2015)CrossRefPubMedPubMedCentral A.E. Teo, S. Garg, L.H. Shaikh et al. Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations. N. Engl. J. Med. 373(15), 1429–1436 (2015)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat J. Zhou, E.A.B. Azizan, C.P. Cabrera et al. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause. Nat. Genet 53(9), 1360–1372 (2021)CrossRefPubMedPubMedCentral J. Zhou, E.A.B. Azizan, C.P. Cabrera et al. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause. Nat. Genet 53(9), 1360–1372 (2021)CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat P. Konstantakou, G. Mastorakos, N. Vrachnis, J.W. Tomlinson, G. Valsamakis, Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond. J. Matern Fetal Neonatal Med 30(3), 284–293 (2017)CrossRefPubMed P. Konstantakou, G. Mastorakos, N. Vrachnis, J.W. Tomlinson, G. Valsamakis, Dysregulation of 11beta-hydroxysteroid dehydrogenases: implications during pregnancy and beyond. J. Matern Fetal Neonatal Med 30(3), 284–293 (2017)CrossRefPubMed
Metadaten
Titel
The mystery of transient pregnancy-induced cushing’s syndrome: a case report and literature review highlighting GNAS somatic mutations and LHCGR overexpression
verfasst von
Yufei Li
Jianfan Lin
Shien Fu
Li Li
Zhenxing Huang
Haiyan Yang
Xinghuan Liang
Yingfen Qin
Jia Zhou
Deyun Liu
Zuojie Luo
Publikationsdatum
12.10.2023
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2024
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03549-7

Weitere Artikel der Ausgabe 2/2024

Endocrine 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.